These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36722655)

  • 21. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM; Hoffman BF
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration.
    Ellis EJ; Ravis WR; Malloy M; Duran SH; Smyth BG
    J Vet Pharmacol Ther; 1994 Aug; 17(4):265-70. PubMed ID: 7525982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined pharmacokinetic and pharmacodynamic model analysis for procainamide and its metabolite].
    Liu XQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):7-11. PubMed ID: 1719744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of fluorescence polarization immunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine.
    Tisdale JE; Padhi ID; Ware JA; Svensson CK
    Ther Drug Monit; 1996 Dec; 18(6):693-7. PubMed ID: 8946667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of evoked endocardial response for assessment of antiarrhythmic drug effects on myocardium.
    Furukawa T; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):33-44. PubMed ID: 2466578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct determination of procainamide and N-acetylprocainamide by capillary zone electrophoresis in pharmaceutical formulations and urine.
    Vargas G; Havel J; Hadasová E
    J Chromatogr A; 1997 Jun; 772(1-2):271-6. PubMed ID: 9226929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Simultaneous predictions of disposition kinetics of procainamide and its metabolite N-acetylprocainamide in rat by a physiological pharmacokinetic model].
    Liu XD; Deng N; Huang SK
    Yao Xue Xue Bao; 1991; 26(10):725-32. PubMed ID: 1726674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
    Winkle RA; Jaillon P; Kates RE; Peters F
    Am J Cardiol; 1981 Jan; 47(1):123-30. PubMed ID: 6161534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1997 Jan; 120(2):187-92. PubMed ID: 9117108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of N-acetylprocainamide deacetylation.
    Stec GP; Ruo TI; Thenot JP; Atkinson AJ; Morita Y; Lertora JJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):659-66. PubMed ID: 6160014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the autonomic effects of procainamide and N-acetylprocainamide in the dog.
    Reynolds RD; Gorczynski RJ
    J Pharmacol Exp Ther; 1980 Mar; 212(3):579-83. PubMed ID: 6153717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antiarrhythmic effects of procainamide, N-acetylprocainamide, and p-hydroxy-N-(3-diethylaminopropyl)benzamide.
    Reynolds RD; Burmeister WE; Calzadilla SV; Lee RJ; Reidenberg MM; Drayer DE
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):156-60. PubMed ID: 6174988
    [No Abstract]   [Full Text] [Related]  

  • 39. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
    Dise T; Stolfi A; Yamasaki S; Pickoff AS
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1994 Mar; 111(3):717-22. PubMed ID: 8019750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.